JPS634821B2 - - Google Patents
Info
- Publication number
- JPS634821B2 JPS634821B2 JP56073511A JP7351181A JPS634821B2 JP S634821 B2 JPS634821 B2 JP S634821B2 JP 56073511 A JP56073511 A JP 56073511A JP 7351181 A JP7351181 A JP 7351181A JP S634821 B2 JPS634821 B2 JP S634821B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- amino
- acid
- mmol
- dryness
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Description
本発明は制がん性物質として有用なN−〔4−
(3−アミノプロピル)アミノブチル〕−2−
〔(S)−7−グアニジノ−3−ヒドロキシヘプタ
ンアミド〕−2−ヒドロキシエタンアミドまたは
その3−0−アシル誘導体の合成中間体として有
用な新規化合物(S)−7−グアニジノ−3−ヒ
ドロキシヘプタンアミドおよびその製造方法に関
する。
第1の本発明は、新規化合物である次式()
で表わされる(S)−7−グアニジノ−3−ヒド
ロキシヘプタンアミドにあり、その塩酸塩は結晶
性白色粉末で、分解点101−103℃を示し、〔α〕22 D
−2゜(C2、水)を示す。元素分析値は
C8H18N4O2・HClの理論値(C40.25%、H7.60
%、N23.47%、Cl29.71%)に合致し、FDマスス
ペクトルでm/e203(MH+)を示した。重水中で
測定したプロトンNMRで、δ1.8−2.3(4−、5
−、6−CH2)、2.95(2−CH2、J=2および6
Hz)、3.69(7−CH2、t、J=7Hz)、4.5(3−
CH)に特徴的なシグナルを示した。本発明によ
る(S)−7−グアニジノ−3−ヒドロキシヘプ
タンアミドは、その安定性から通常酸付加塩とし
て得ることが好ましい。付加すべき酸としては、
塩酸、硫酸、リン酸、ホウ酸などの無機塩、酢
酸、クエン酸、酒石酸、グルタル酸などの有機酸
が用いられる。
第2の本発明は、L−リジンから出発して
Arndt−Eistert反応(ジヤーナル・オブ・オルガ
ニツク・ケミストリー、17巻、347頁、1952年)
によつて、(S)−3・7−ジアミノヘプタン酸を
生成し、続いてβ−アミノ基を亜硝酸塩で脱アミ
ノ化し、カルボキシル基をアミド基に、さらにア
ミノ基をグアニジン基に変換して(S)−7−グ
アニジノ−3−ヒドロキシヘプタンアミドを合成
する製造法にある。
次に本製造法を具体的に述べる。すなわち、次
式()
で表わされるL−リジンの2個のアミノ基をアミ
ノ保護基で保護して次式(−1)
〔式中、Aは水素原子で、Bが1価のアミノ保護
基であるか、AおよびBが共同して2価のアミノ
保護基であることを示す〕で表わされるアミノ保
護体とした。アミノ保護基としては従来ペプチド
合成で常用されているアミノ保護基を使用しうる
が、本発明の方法においては2価のアミノ保護基
としてフタロイル基を使用することが好ましい。
L−リジンの2個のアミノ基にフタロイル基を導
入するには、常法により水溶液中過剰のN−エト
キシカルボニルフタルイミドの反応によつて行な
われる。
次に上記のアミノ保護体のカルボキシル基を次
の一般式(−2)
で表わされる酸塩化物(Rが−COClの場合)と
した。酸塩化物とするには塩化チオニルや塩化オ
キザリルによる常法によつて行われる。続いてエ
ーテル中ジアゾメタンで処理してジアゾメチル基
を導入し〔(−2)式でRが−COCHN2の場
合〕、メタノール中安息香酸銀を触媒として室温
で転移せしめるArndt−Eistert反応によつて炭素
鎖を1個伸長したカルボン酸のエステル〔(−
2)式でRが−CH2COOCH3の場合〕とした。
次に常法によつてアミノ保護基およびカルボキシ
ル保護基を除去して次式()
で表わされる(S)−3・7−ジアミノヘプタン
酸を合成した。
次に、(S)−3・7−ジアミノヘプタン酸の7
位のアミノ基のみをアミノ保護基で保護し、次の
一般式(−1)
(式中Aは水素原子で、Bが1価のアミノ保護基
であるか、AおよびBが共同して2価のアミノ保
護基であることを示す)で表わされるアミノ保護
体とした。アミノ保護基としては前記同様ペプチ
ド合成で常用されている保護基を使用しうるが、
こゝでは保護基の除去方法が簡単なベンジルオキ
シカルボニル基や第三ブトキシカルボニル基など
が用いられる。7位の一級アミノ基は3位の二級
アミノ基よりも反応性が強いのでアミノ基の保護
に使用するアシル化剤の使用量を1当量に制限す
ることにより通常7位のアミノ保護体が優先して
生成する。アシル化剤としては公知の酸アミド、
活性エステルなどを使用するのが好ましい。
次に、3位のアミノ基を脱アミノ化し、次の一
般式(−2)
(式中、A、Bは前述に同じ、RがOHを示す)
で表わされる3−ヒドロキシ体を合成した。脱ア
ミノ化反応は常法によつて酢酸水溶液中亜硝酸塩
によつて処理し、立体化学の同じ3−ヒドロキシ
体を得た。
この3−ヒドロキシ体をエーテル中ジアゾメタ
ンで処理してメチルエステルとし〔(−2)式
でRがOCH3の場合〕、常法によりメタノール中
アンモニアを反応せしめてアミドとし〔(−2)
式でRがNH2の場合〕、アミノ保護基を除去して
次式()
で表わされる(S)−7−アミノ−3−ヒドロキ
シヘプタン酸アミドを合成した。
続いて7位のアミノ基をグアニジン基に変換し
て次式()
で表わされる(S)−7−グアニジノ−3−ヒド
ロキシヘプタンアミドを合成した。7位のアミノ
基をグアニジン基に変換するには、アルカリ性水
溶液中1当量の2−メチル−1−ニトロイソ尿
素、S−メチルチオ尿素などを反応せしめてグア
ニジン基とすることができる。例えば前者を使用
した場合、グアニジン基の保護基であるニトロ基
は、パラジウム、酸化白金などを触媒とする通常
の加水分解によつて容易に脱離することができ
る。
本発明化合物を用いて制がん性物質として有用
なN−〔4−(3−アミノプロピル)アミノブチ
ル〕−2−〔(S)−7−グアニジノ−3−ヒドロキ
シヘプタンアミド〕−2−ヒドロキシエタンアミ
ド(以下GHA−GSと略す)を合成するには、本
発明の前記式()の化合物と次式
で表わされるN−〔4−3−アミノプロピル)ア
ミノブチル〕−2・2−ジヒドロキシエタンアミ
ドを無機酸または有機酸の存在下で加熱縮合する
ことによつて得ることができる。
GHA−GSは次に示すようにマウス白血病
L1210に対して制ガン効果を示し、制ガン剤とし
て有用なものである。
マウス白血病L1210に対する制ガン効果一群5
匹の雄性BDF1系マウス(6週令)にL1210細胞
105個を腹腔内に接種し、その直後より生理食塩
水に溶解した試料を1日1回6日間連続で腹腔内
に投与し、延命率(T/C=処理群の平均生存日
数/無処理群の平均生存日数)を求めた。その結
果を次表に示す。
The present invention provides N-[4-
(3-aminopropyl)aminobutyl]-2-
[(S)-7-guanidino-3-hydroxyheptaneamide] Novel compound (S)-7-guanidino-3-hydroxyheptane useful as a synthetic intermediate for -2-hydroxyethanamide or its 3-0-acyl derivative This invention relates to amides and methods for producing the same. The first invention is a novel compound of the following formula () The hydrochloride is a crystalline white powder with a decomposition point of 101-103°C, [α] 22 D
-2° (C2, water) is shown. The elemental analysis value is
Theoretical value of C 8 H 18 N 4 O 2・HCl (C40.25%, H7.60
%, N23.47%, Cl29.71%), and the FD mass spectrum showed m/e203 (MH + ). Proton NMR measured in heavy water shows δ1.8−2.3(4−,5
-, 6-CH 2 ), 2.95 (2-CH 2 , J=2 and 6
Hz), 3.69 (7-CH 2 , t, J = 7Hz), 4.5 (3-CH 2 , t, J = 7Hz),
CH) showed a characteristic signal. (S)-7-guanidino-3-hydroxyheptanamide according to the present invention is usually preferably obtained as an acid addition salt in view of its stability. The acid to be added is
Inorganic salts such as hydrochloric acid, sulfuric acid, phosphoric acid, and boric acid, and organic acids such as acetic acid, citric acid, tartaric acid, and glutaric acid are used. The second invention starts from L-lysine.
Arndt-Eistert reaction (Journal of Organic Chemistry, vol. 17, p. 347, 1952)
to produce (S)-3,7-diaminoheptanoic acid, followed by deamination of the β-amino group with nitrite, converting the carboxyl group to an amide group and the amino group to a guanidine group. It is a manufacturing method for synthesizing (S)-7-guanidino-3-hydroxyheptanamide. Next, this manufacturing method will be specifically described. That is, the following formula () Two amino groups of L-lysine represented by are protected with an amino protecting group to form the following formula (-1) [In the formula, A is a hydrogen atom, B is a monovalent amino protecting group, or A and B jointly represent a divalent amino protecting group]. As the amino protecting group, amino protecting groups conventionally used in peptide synthesis can be used, but in the method of the present invention, it is preferable to use a phthaloyl group as the divalent amino protecting group.
Introducing phthaloyl groups into the two amino groups of L-lysine is carried out by reacting excess N-ethoxycarbonylphthalimide in an aqueous solution in a conventional manner. Next, the carboxyl group of the above amino-protected product is expressed by the following general formula (-2). The acid chloride represented by (when R is -COCl) was used. Acid chlorides can be obtained by conventional methods using thionyl chloride or oxalyl chloride. Subsequently, a diazomethyl group is introduced by treatment with diazomethane in ether [when R is -COCHN 2 in formula (-2)], and carbon is transferred by Arndt-Eistert reaction in methanol with silver benzoate as a catalyst at room temperature. Ester of carboxylic acid with one chain extended [(-
2) where R is -CH 2 COOCH 3 ].
Next, the amino protecting group and the carboxyl protecting group are removed by a conventional method, and the following formula () is obtained. (S)-3,7-diaminoheptanoic acid represented by was synthesized. Next, 7 of (S)-3,7-diaminoheptanoic acid
Only the amino group at position is protected with an amino protecting group, and the following general formula (-1) is obtained. (In the formula, A is a hydrogen atom, and B is a monovalent amino protecting group, or A and B jointly represent a divalent amino protecting group). As the amino protecting group, protecting groups commonly used in peptide synthesis can be used as described above, but
In this case, a benzyloxycarbonyl group, a tert-butoxycarbonyl group, etc., whose protecting group can be easily removed, are used. The primary amino group at the 7-position is more reactive than the secondary amino group at the 3-position, so by limiting the amount of acylating agent used to protect the amino group to 1 equivalent, the amino-protected form at the 7-position is usually protected. Generate with priority. Known acid amides as acylating agents,
Preferably, active esters and the like are used. Next, the amino group at position 3 is deaminated to give the following general formula (-2) (In the formula, A and B are the same as above, and R represents OH)
A 3-hydroxy compound represented by was synthesized. The deamination reaction was carried out using nitrite in an aqueous acetic acid solution in a conventional manner to obtain the 3-hydroxy form with the same stereochemistry. This 3-hydroxy form is treated with diazomethane in ether to form a methyl ester [when R is OCH 3 in formula (-2)], and reacted with ammonia in methanol by a conventional method to form an amide [(-2)].
When R is NH 2 in the formula], remove the amino protecting group and convert to the following formula () (S)-7-amino-3-hydroxyheptanoic acid amide represented by was synthesized. Next, convert the amino group at position 7 to a guanidine group to form the following formula () (S)-7-guanidino-3-hydroxyheptanamide represented by was synthesized. In order to convert the amino group at the 7-position into a guanidine group, a guanidine group can be obtained by reacting 1 equivalent of 2-methyl-1-nitroisourea, S-methylthiourea, etc. in an alkaline aqueous solution. For example, when the former is used, the nitro group, which is a protective group for the guanidine group, can be easily removed by conventional hydrolysis using palladium, platinum oxide, or the like as a catalyst. N-[4-(3-aminopropyl)aminobutyl]-2-[(S)-7-guanidino-3-hydroxyheptanamide]-2-hydroxy useful as an anticancer substance using the compound of the present invention To synthesize ethanamide (hereinafter abbreviated as GHA-GS), the compound of the above formula () of the present invention and the following formula It can be obtained by heating and condensing N-[4-3-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide represented by in the presence of an inorganic or organic acid. GHA-GS is a murine leukemia as shown below.
It shows anticancer effects against L1210 and is useful as an anticancer agent. Anticancer effect on mouse leukemia L1210 group 5
L1210 cells in male BDF 1 mice (6 weeks old)
Immediately after, a sample dissolved in physiological saline was intraperitoneally administered once a day for 6 consecutive days, and the survival rate (T / C = average survival days of treated group/no The average survival days of the treated group was determined. The results are shown in the table below.
【表】
次に実施例を示す。
実施例
(a) (S)−3・7−ジアミノヘプタン酸の合成
L−リジン塩酸塩15g(82.15ミリモル)を
水500mlにとかし、炭酸ナトリウム8.7g
(82.15ミリモル)とN−エトキシカルボニルフ
タルイミド43.2g(200ミリモル)を加え、室
温で20時間撹拌した。反応液を50mlの酢酸エチ
ルで洗浄したのち、水層を6N塩酸でPH3.0と
し、トルエン100mlで3回抽出した。抽出液を
PH2.0に調整した水100mlで2回洗浄したのち、
無水硫酸ナトリウムで脱水し、減圧濃縮乾固し
てジ−N−フタロイル−L−リジンの白色粉末
27.95gを得た。収率84%、分解点71−72℃、
〔α〕22 D−32゜(C1、メタノール)。
ジ−N−フタロイル−L−リジン27.0g
(66.4ミリモル)に塩化オキザリル40mlを加え
90℃の油浴で加温したのち、1・2−ジメトキ
シエタン40mlを加え2時間加温還流した。反応
液を濃縮乾固したのち、再び1・2−ジメトキ
シエタン20mlにとかし、氷冷下ジアゾメタン
(330ミリモル)のエーテル溶液500ml中に滴下
し、続いて1時間撹拌した。反応液を濃縮乾固
し、無水メタノール250mlにとかし、安息香酸
銀3.4g(14.8ミリモル)をトリエチルアミン
50mlにとかした溶液を加え室温で15時間撹拌し
た。沈澱を取し、クロロホルム100mlにとか
し、不溶物を去したのち、濃縮乾固して、
(S)−3・7−ジフタロイルアミノヘプタン酸
メチルエステル15.3gを得た。収率53%、分解
点118−119℃、〔α〕22 D−3゜(C2、クロロホル
ム)。
(S)−3・7−ジフタロイルアミノヘプタ
ン酸メチルエステル15.0g(34.5ミリモル)に
1Mエタノール性抱水ヒドラジン100mlと95%エ
タノール100mlを加え1時間加熱還流した(油
浴温度90℃)。反応液を濃縮乾固し、5%塩酸
250mlにとかし、80℃で1時間加温したのち、
17%アンモニア水でPH7.1とし、アンバーライ
トCG−50(70%NH4型)300mlをつめた塔(内
径27mm)にかけ、続いてそれぞれ900mlの水と
0.2Mアンモニア水で洗浄し、0.5Mアンモニア
水で溶出し、ニンヒドリン陽性の分画を集めて
濃縮乾固し、無色アメ状の(S)−3・7−ジ
アミノヘプタン酸(C7H16N2O2・1/4H2CO3)
3.15gを得た。収率57%、〔α〕21 D+29゜(C1、
水)。
(b) (S)−7−グアニジノ−3−ヒドロキシヘ
プタンアミドの合成
前項(a)で得られた(S)−3・7−ジアミノ
ヘプタン酸3.1g(19.3ミリモル)をピリジン
−水−トリエチルアミン(10:10:1容)の混
液30mlにとかし、N−ベンジルオキシカルボニ
ルオキシコハク酸イミド4.81g(19.3ミリモ
ル)を徐々に加え、室温で5時間撹拌した。反
応液を濃縮乾固し、水30mlにとかし、6N塩酸
でPH6.4とし、アンバーライトCG−50(80%
NH4型)100mlの塔(内径16mm)にかけ、300
mlの水で展開した。流出液を集めてさらにダウ
エツクス50W−X4(H型)100mlの塔(内径16
mm)にかけ、それぞれ300mlの水および0.2Mア
ンモニア水で洗浄したのち、0.5Mアンモニア
水で溶出し(10ml分画)、分画16〜33を合して
濃縮乾固し、(S)−3−アミノ−7−ベンジル
オキシカルボニルアミノヘプタン酸
(C15H22N2O4・H2O)の白色粉末2.73gを得
た。収率48%、分解点143−147℃、〔α〕22 D+
14゜(C1、メタノール)。なお、アンバーライト
CG−50の塔を0.5アンモニア水で溶出して
(S)−3・7−ジアミノヘプタン酸746mgを回
収した。回収率24%。
(S)−3−アミノ−7−ベンジルオキシカ
ルボニルアミノヘプタン酸2.7g(9.17ミリモ
ル)を33%酢酸水にとかし、亜硝酸ナトリウム
1.9g(27.51ミリモル)を水10mlにとかした溶
液を氷冷下1時間かけて加え、さらに1時間撹
拌したのち、5℃24時間放置した。反応液に水
50mlを加え、酢酸エチル50mlで2回抽出し、溶
媒層を無水硫酸ナトリウムで脱水し、濃縮乾固
して2.16gの粗粉末を得た。これをシリカゲル
(ワコーゲルC−200)200gのカラムクロマト
グラフイー(内径28mm)でクロロホルム−メタ
ノール−濃アンモニア水(30:10:1容)の混
液によつて展開し(20ml分画)、分画51−60を
合して濃縮乾固し、(S)−7−ベンジルオキシ
カルボニルアミノ−3−ヒドロキシヘプタン酸
の白色粉末460mgを得た。収率17%、分解点115
−117℃、〔α〕23 D+3゜(C2、メタノール)。
(S)−7−ベンジルオキシカルボニルアミ
ノ−3−ヒドロキシヘプタン酸450mg(1.52ミ
リモル)を1・2−ジメトキシエタンにとか
し、ジアゾメタンのエーテル溶液7ml(4.56ミ
リモル)を氷冷下滴加し、30分撹拌した。反応
液を濃縮乾固して、(S)−7−ベンジルオキシ
カルボニルアミノ−3−ヒドロキシヘプタン酸
メチルエステル461mgを得た。収率98%、〔α〕
21 D1゜。
(S)−7−ベンジルオキシカルボニルアミ
ノ−3−ヒドロキシヘプタン酸メチルエステル
450mg(1.45ミリモル)を無水メタノール50ml
にとかし、−10℃に冷却し、アンモニアガスを
飽和せしめたのち、封管中で室温3日間放置し
た。反応液を濃縮乾固したのち、シリカゲル
(ワコーゲルC−200)50gのカラム(内径20
mm)で、クロロホルム−メタノール(100:1
容)で展開するクロマトグラフイーを行ない、
10mlずつ分画し、分画82−106を合して濃縮乾
固し、(S)−7−ベンジルオキシカルボニルア
ミノ−3−ヒドロキシヘプタンアミドの白色粉
末371mgを得た。収率87%、分解点126−127℃、
〔α〕22 D−3゜(C5、メタノール)。
(S)−7−ベンジルオキシカルボニルアミ
ノ−3−ヒドロキシヘプタンアミド350mg
(1.19ミリモル)を90%メタノール水10mlと酢
酸0.01mlの混液にとかし、5%パラジウム−炭
素50mgを加え、水素気流中室温で3時間撹拌触
媒を去し、液を濃縮乾固し、再び少量の水
にとかしてダウエツクス50W−X4(H型)30ml
の塔(内径12mm)にかけ、90mlの水で洗浄後、
0.5Mアンモニア水で溶出した(3ml分画)。分
画28−34を合して濃縮乾固し、(S)−7−アミ
ノ−3−ヒドロキシヘプタンアミド201mgを得
た。収率96%、〔α〕22 D−2゜(C2、水)。
(S)−7−アミノ−3−ヒドロキシヘプタ
ンアミド190mg(1.08ミリモル)を3mlの水に
とかし、2N苛性ソーダ0.54mlを加えて、2−
メチル−1−ニトロソウレア129mg(1.08ミリ
モル)を含むメタノール溶液1mlを氷冷下30分
間滴加し、さらに5時間撹拌した。反応液を
6N塩酸でPH6.0とし、濃縮乾固した。これをシ
リカゲル(ワコーゲルC−200)30gのカラム
(内径15mm)によりクロロホルム−メタノール
−濃アンモニア水(60:10:1容)の混液で展
開するクロマトグラフイーによつて精製した
(6ml分画)。分画67−90を合して濃縮乾固し、
(S)−7−ニトログアニジノ−3−ヒドロキシ
ヘプタンアミドの白色粉末187mgを得た。収率
70%、分解点148−149℃、〔α〕22 D−2゜(C2、メ
タノール)。
(S)−7−ニトログアニジノ−3−ヒドロ
キシヘプタンアミド170mg(0.69ミリモル)を
水15ml、メタノール15ml、酢酸7.5mlの混液に
とかし、5%パラジウム−炭素50mgを加え、水
素気流中室温で1時間撹拌した。触媒を去
し、液を濃縮乾固して165mgの粗粉末を得た。
これを10mlの水にとかし、CM−セフアデツク
スC−25(Na型)20mlをつめた塔(内径12mm)
にかけ0.5MNaClで溶出した(2ml分画)。分
画18−25を合して濃縮乾固した。これをメタノ
ール10mlで3回抽出し、このメタノール溶液を
合してセフアデツクスLH−20を100ml充填し
た塔(内径20mm)にかけ、メタノールで展開し
た(1ml分画)。分画28−46を合して濃縮乾固
し、(S)−7−グアニジノ−3−ヒドロキシヘ
プタンアミド塩酸塩(C8H18N4O2・HCl)の白
色粉末149mgを得た。収率91%、〔α〕22 D−2゜
(C2、水)。
参考例
GHA−GSの合成
(S)−7−グアニジノ−3−ヒドロキシヘプ
タン塩酸塩51mg(0.214ミリモル)、N−〔4−(3
−アミノプロピル)アミノブチル〕−2・2−ジ
ヒドロキシエタンアミド二塩酸塩112mg(0.385ミ
リモル)、グルタル酸70mg(0.53ミリモル)と水
0.07ml(3.9ミリモル)を混和し、60℃で43時間
撹拌した。反応液0.4MNaCl20mlを加え、10%ア
ンモニア水でPH6.1とし、0.4MNaClで平衡化した
CM−セフアデツクスC−25 20mlをつめた塔
(内径12mm)にかけ、続いて各80mlの0.4Mと
1.0MのNaClによるグラジエント溶出を行なつた
(2ml分画)。分画41−50を合し、濃縮乾固後メタ
ノール10mlで3回抽出した。メタノール抽出液を
セフアデツクスLH−20 100mlをつめた塔(内径
20mm)にかけメタノールで展開した(1ml分画)。
分画30−42を合して濃縮乾固し、N−〔4−(3−
アミノプロピル)アミノブチル〕−2−〔(S)−7
−グアニジノ−3−ヒドロキシヘプタンアミド〕
−2−ヒドロキシエタンアミド(GHA−GS)三
塩酸塩の白色粉末38.4mgを得た。収率35%。
GHA−GS三塩酸塩は吸湿性粉末で、明確な融
点を測定できず、〔α〕22 D−1゜±2゜(C2、水)を示
し
た。元素分析値はC17H37N7O4・3HClの理論値
(C39.81%、H7.86%、N19.12%、Cl20.73%)に
合致した。重水中で測定したプロトンNMRで
δ1.8−2.3(CH2×5)、2.57(6″−CH2)、2.95(2
−
CH2)、3.5−3.8(NCH2×5)、4.55(3−CH)、
5.98(2′−CH)に特徴的なシグナルを示した。
なお、本参考例で用いたN−〔4−(3−アミノ
プロピル)アミノブチル〕−2・2−ジヒドロキ
シエタンアミドは下記のようにして製造される。
N−〔4−(3−アミノプロピル)アミノブチ
ル〕−2・2−ジヒドロキシエタンアミドの合成
(a) モノ−N−ベンジルオキシカルボニル−1・
4−ブタンジアミンの合成
1・4−ブタンジアミン1.76g(20ミリモ
ル)を50%メタノール水30mlにとかし、ベンジ
ルS−4・6−ジメチルピリミド−2−イルチ
オカルボネート(国産化学(株)製)5.48g(20ミ
リモル)を加え、3時間撹拌する。反応後、沈
澱を去し、(ジ−N−ベンジルオキシカルボ
ニル体2.08g、29%を得た)、液を濃縮乾固
した。残渣を250mlのクロロホルムにとかし、
水100mlで5回洗浄し、クロロホルム層を無水
硫酸ナトリウムで脱水し、濃縮乾固してモノ−
N−ベンジルオキシカルボニル−1・4−ブタ
ンジアミンの無色アメ状物質1.0gを得た。収
率23%。
(b) 0−トシル−3−第三ブトキシカルボニルア
ミノ−1−プロパノールの合成
3−アミノ−1−プロパノール1.5g(20ミ
リモル)をメタノール30mlにとかし、第三ブチ
ルS−4・6−ジメチルピリミド−2−イルチ
オカルボネート(国産化学(株)製)4.8g(20ミ
リモル)を加え、6時間撹拌した。反応液を濃
縮乾固し、クロロホルム200mlにとかし、200ml
の水で洗浄した。クロロホルム層を濃縮し、シ
リカゲル(ワコーゲルC−200)300gによるカ
ラムクロマトグラフイーでトルエン−酢酸エチ
ル(1:1容)の混液で展開し(15ml分画)、
分画82−151を合して濃縮乾固し、3−第三ブ
トキシカルボニルアミノ−1−プロパノールの
無色油状物質2.95gを得た。収率84%。
3−第三ブトキシカルボニルアミノ−1−プ
ロパノール2.95g(16.9ミリモル)をピリジン
50mlにとかし、アルゴン中氷冷下に、塩化パラ
トルエンスルホニル3.36g(17.7ミリモル)を
含むピリジン溶液を40分間で滴加した。さらに
7℃で一夜放置したのち、少量の水を加え濃縮
乾固した。残渣をクロロホルム200mlにとかし、
5%硫酸水素カリウム水溶液、飽和炭酸水素ナ
トリウム水溶液および水で順次洗浄したのち、
無水硫酸ナトリウムで脱水し、濃縮乾固した。
これをシリカゲル(ワコーゲルC−200)120g
によるカラムクロマトグラフイーでトルエン−
酢酸エチル(8:1容)の混液で展開し(15ml
分画)、分画35−68を合して濃縮乾固し、0−
トシル−3−第三ブトキシカルボニルアミノ−
1−プロパノールの無色油状物質3.06gを得
た。収率55%。
(c) N−第三ブトキシカルボニル−N−(第三ブ
トキシカルボニルアミノプロピル)−1・4−
ブタンジアミンの合成
(b)項で得られた0−トシル−3−第三ブトキ
シカルボニルアミノ−1−プロパノール800mg
(2.43ミリモル)をジメチルホルムアミド15ml
にとかし、臭化リチウム(LiBrH2O)510mg
(4.8ミリモル)を加え室温で24時間撹拌した。
このブロム体の反応液に(a)項で得られたモノ−
N−ベンジルオキシカルボニル−1・4−ブタ
ンジアミン540mg(2.43ミリモル)とトリエチ
ルアミン0.34mlを加え、室温で48時間撹拌し
た。この反応液に第三ブチルS−4・6−ジメ
チルピリミド−2−イルチオカルボネート699
mg(2.9ミリモル)を加え、室温で13時間撹拌
した。反応液を濃縮乾固し、残渣をクロロホル
ム100mlにとかし、50mlの水で洗浄したのち、
無水硫酸ナトリウムで脱水し濃縮乾固した。こ
れをシリカゲル(ワコーゲルC−200)200gに
よるカラムクロマトグラフイーでトルエン−酢
酸エチル(4:1容)の混液で展開し(12ml分
画)、分画134〜165を合して濃縮乾固し、N−
ベンジルオキシカルボニル−N′−第三ブトキ
シカルボニル−N′−(第三ブトキシカルボニル
アミノプロピル)−1・4−ブタンジアミンの
無色アメ状物質608mgを得た。収率52%。
このアメ状物質144mg(0.3ミリモル)をメタ
ノール5mlにとかし、5%パラジウム−炭酸バ
リウム100mgを加え、水素気流中室温で5時間
撹拌した。触媒を去し、液を濃縮乾固し
て、N−第三ブトキシカルボニル−N−(第三
ブトキシカルボニルアミノプロピル)−1・4
−ブタンジアミン103mgを得た。収率100%。
(d) N−〔4−(3−アミノプロピル)アミノブチ
ル〕−2・2−ジヒドロキシエタンアミドの合
成
(c)項で得たN−第三ブトキシカルボニル−N
−(第三ブトキシカルボニルアミノプロピル)−
1・4−ブタンジアミン100mg(0.29ミリモル)
と2・2−ジエトキシ酢酸148mg(1ミリモル)
を酢酸エチル2mlにとかし、さらに1−ヒドロ
キシベンツトリアゾール135mg(1ミリモル)
およびジシクロヘキシルカルボジイミド206mg
(1ミリモル)を加え室温で15時間撹拌した。
沈澱を去し、冷酢酸エチルで洗浄し、液と
洗液を合し、1Mアンモニア水および水で順次
洗浄した。酢酸エチル層を無水硫酸ナトリウム
で脱水して濃縮乾固した。これをシリカゲル
(ワコーゲルC−200)20gのカラムクロマトグ
ラフイーでトルエン−酢酸エチル(1:2容)
の混液で展開し(3ml分画)、分画14−21を合
して濃縮乾固し、N−〔4−(3−第三ブトキシ
カルボニルアミノプロピル)−4−第三ブトキ
シカルボニルアミノブチル〕−2・2−ジエト
キシエタンアミドの無色アメ状物質109mgを得
た。収率79%。
このアメ状物質44mg(0.13ミリモル)をジオ
キサン1mlにとかし、0.1N塩酸2.5mlを加え、
100℃の油浴中で4時間撹拌した。反応液を
0.2NNaOHで中和し(PH6)、濃縮乾固した。
残渣を1.5mlのメタノールで抽出し、セフアデ
ツクスLH−20 100mlのカラム(内径16.5mm)
にかけメタノールで展開した(2ml分画)。ニ
ンヒドリン反応陽性の分画22−25を合して、濃
縮乾固し、N−〔4−(3−アミノプロピル)ア
ミノブチル〕−2・2−ジヒドロキシエタンア
ミド二塩酸塩の無色アメ状物質13mgを得た。収
率46%。[Table] Examples are shown next. Example (a) Synthesis of (S)-3,7-diaminoheptanoic acid Dissolve 15 g (82.15 mmol) of L-lysine hydrochloride in 500 ml of water and add 8.7 g of sodium carbonate.
(82.15 mmol) and 43.2 g (200 mmol) of N-ethoxycarbonylphthalimide were added, and the mixture was stirred at room temperature for 20 hours. After washing the reaction solution with 50 ml of ethyl acetate, the aqueous layer was adjusted to pH 3.0 with 6N hydrochloric acid and extracted three times with 100 ml of toluene. extract liquid
After washing twice with 100ml of water adjusted to PH2.0,
Dehydrated with anhydrous sodium sulfate and concentrated to dryness under reduced pressure to obtain a white powder of di-N-phthaloyl-L-lysine.
Obtained 27.95g. Yield 84%, decomposition point 71-72℃,
[α] 22 D −32° (C1, methanol). Di-N-phthaloyl-L-lysine 27.0g
(66.4 mmol) and added 40 ml of oxalyl chloride.
After heating in a 90°C oil bath, 40 ml of 1,2-dimethoxyethane was added and heated under reflux for 2 hours. After the reaction solution was concentrated to dryness, it was again dissolved in 20 ml of 1,2-dimethoxyethane, added dropwise to 500 ml of an ether solution of diazomethane (330 mmol) under ice cooling, and then stirred for 1 hour. The reaction solution was concentrated to dryness, dissolved in 250 ml of anhydrous methanol, and 3.4 g (14.8 mmol) of silver benzoate was added to triethylamine.
A solution dissolved in 50 ml was added and stirred at room temperature for 15 hours. The precipitate was collected, dissolved in 100 ml of chloroform to remove insoluble materials, and concentrated to dryness.
15.3 g of (S)-3,7-diphthaloylaminoheptanoic acid methyl ester was obtained. Yield 53%, decomposition point 118-119°C, [α] 22 D −3° (C2, chloroform). (S)-3,7-diphthaloylaminoheptanoic acid methyl ester 15.0g (34.5 mmol)
100 ml of 1M ethanolic hydrazine hydrate and 100 ml of 95% ethanol were added and heated under reflux for 1 hour (oil bath temperature: 90°C). The reaction solution was concentrated to dryness and added with 5% hydrochloric acid.
After stirring to 250ml and heating at 80℃ for 1 hour,
The pH was adjusted to 7.1 with 17% ammonia water and poured into a column (inner diameter 27 mm) filled with 300 ml of Amberlite CG-50 (70% NH 4 type), followed by 900 ml of water each.
Wash with 0.2M ammonia water, elute with 0.5M ammonia water, collect ninhydrin-positive fractions and concentrate to dryness to obtain colorless candy-like (S)-3,7-diaminoheptanoic acid (C 7 H 16 N 2 O 2・1/4H 2 CO 3 )
3.15g was obtained. Yield 57%, [α] 21 D +29° (C1,
water). (b) Synthesis of (S)-7-guanidino-3-hydroxyheptanamide 3.1 g (19.3 mmol) of (S)-3,7-diaminoheptanoic acid obtained in the previous section (a) was added to pyridine-water-triethylamine ( 4.81 g (19.3 mmol) of N-benzyloxycarbonyloxysuccinimide was gradually added to the mixture, and the mixture was stirred at room temperature for 5 hours. The reaction solution was concentrated to dryness, dissolved in 30 ml of water, adjusted to pH 6.4 with 6N hydrochloric acid, and mixed with Amberlite CG-50 (80%
NH4 type) into a 100ml column (inner diameter 16mm),
Developed with ml of water. The effluent was collected and added to a Dowex 50W-X4 (H type) 100ml tower (inner diameter 16mm).
mm), washed with 300 ml of water and 0.2 M ammonia water, and eluted with 0.5 M ammonia water (10 ml fractions). Fractions 16 to 33 were combined and concentrated to dryness. 2.73 g of white powder of -amino-7- benzyloxycarbonylaminoheptanoic acid ( C15H22N2O4.H2O ) was obtained. Yield 48%, decomposition point 143-147℃, [α] 22 D +
14° (C1, methanol). In addition, amber light
The CG-50 column was eluted with 0.5 ammonia water to recover 746 mg of (S)-3,7-diaminoheptanoic acid. Recovery rate: 24%. 2.7 g (9.17 mmol) of (S)-3-amino-7-benzyloxycarbonylaminoheptanoic acid was dissolved in 33% acetic acid water, and sodium nitrite was added.
A solution of 1.9 g (27.51 mmol) dissolved in 10 ml of water was added over 1 hour under ice cooling, stirred for an additional 1 hour, and then left at 5°C for 24 hours. water in reaction solution
50 ml of the solution was added and extracted twice with 50 ml of ethyl acetate, and the solvent layer was dehydrated with anhydrous sodium sulfate and concentrated to dryness to obtain 2.16 g of crude powder. This was developed by column chromatography (inner diameter 28 mm) using 200 g of silica gel (Wako Gel C-200) with a mixture of chloroform, methanol, and concentrated aqueous ammonia (30:10:1 volume) (20 ml fractions), and fractionated. 51-60 were combined and concentrated to dryness to obtain 460 mg of white powder of (S)-7-benzyloxycarbonylamino-3-hydroxyheptanoic acid. Yield 17%, decomposition point 115
−117°C, [α] 23 D +3° (C2, methanol). 450 mg (1.52 mmol) of (S)-7-benzyloxycarbonylamino-3-hydroxyheptanoic acid was dissolved in 1,2-dimethoxyethane, and 7 ml (4.56 mmol) of an ether solution of diazomethane was added dropwise under ice cooling for 30 minutes. Stirred. The reaction solution was concentrated to dryness to obtain 461 mg of (S)-7-benzyloxycarbonylamino-3-hydroxyheptanoic acid methyl ester. Yield 98%, [α]
21 D 1°. (S)-7-Benzyloxycarbonylamino-3-hydroxyheptanoic acid methyl ester
450 mg (1.45 mmol) in 50 ml of absolute methanol
The mixture was stirred, cooled to -10°C, saturated with ammonia gas, and then left in a sealed tube at room temperature for 3 days. After concentrating the reaction solution to dryness, a 50 g column of silica gel (Wako Gel C-200) (inner diameter 20
mm), chloroform-methanol (100:1
Perform chromatography to develop the
The mixture was fractionated into 10 ml portions, and fractions 82-106 were combined and concentrated to dryness to obtain 371 mg of white powder of (S)-7-benzyloxycarbonylamino-3-hydroxyheptanamide. Yield 87%, decomposition point 126-127℃,
[α] 22 D −3° (C5, methanol). (S)-7-benzyloxycarbonylamino-3-hydroxyheptanamide 350 mg
(1.19 mmol) was dissolved in a mixture of 10 ml of 90% methanol water and 0.01 ml of acetic acid, 50 mg of 5% palladium-carbon was added, and the catalyst was stirred at room temperature in a hydrogen stream for 3 hours. The liquid was concentrated to dryness, and a small amount was again added. Dowex 50W-X4 (H type) 30ml dissolved in water.
After washing with 90ml of water,
Elution was performed with 0.5M aqueous ammonia (3 ml fraction). Fractions 28-34 were combined and concentrated to dryness to obtain 201 mg of (S)-7-amino-3-hydroxyheptanamide. Yield 96%, [α] 22 D −2° (C2, water). Dissolve 190 mg (1.08 mmol) of (S)-7-amino-3-hydroxyheptanamide in 3 ml of water, add 0.54 ml of 2N caustic soda, and add 2-
1 ml of a methanol solution containing 129 mg (1.08 mmol) of methyl-1-nitrosourea was added dropwise under ice cooling for 30 minutes, and the mixture was further stirred for 5 hours. reaction solution
The pH was adjusted to 6.0 with 6N hydrochloric acid, and the mixture was concentrated to dryness. This was purified by chromatography using a 30 g column (inner diameter 15 mm) of silica gel (Wako Gel C-200) developed with a mixture of chloroform, methanol, and concentrated aqueous ammonia (60:10:1 volume) (6 ml fractions). . Fractions 67-90 were combined and concentrated to dryness.
187 mg of white powder of (S)-7-nitroguanidino-3-hydroxyheptanamide was obtained. yield
70%, decomposition point 148-149°C, [α] 22 D −2° (C2, methanol). Dissolve 170 mg (0.69 mmol) of (S)-7-nitroguanidino-3-hydroxyheptanamide in a mixture of 15 ml of water, 15 ml of methanol, and 7.5 ml of acetic acid, add 50 mg of 5% palladium-carbon, and hold for 1 hour at room temperature in a hydrogen stream. Stirred. The catalyst was removed and the liquid was concentrated to dryness to obtain 165 mg of crude powder.
Dissolve this in 10ml of water and fill it with 20ml of CM-Sephadex C-25 (Na type) in a tower (inner diameter 12mm).
and eluted with 0.5 M NaCl (2 ml fractions). Fractions 18-25 were combined and concentrated to dryness. This was extracted three times with 10 ml of methanol, and the methanol solutions were combined and applied to a column (inner diameter 20 mm) packed with 100 ml of Sephadex LH-20, and developed with methanol (1 ml fraction). Fractions 28-46 were combined and concentrated to dryness to obtain 149 mg of white powder of (S)-7-guanidino-3- hydroxyheptanamide hydrochloride ( C8H18N4O2.HCl ). Yield 91%, [α] 22 D −2° (C2, water). Reference example Synthesis of GHA-GS (S)-7-guanidino-3-hydroxyheptane hydrochloride 51 mg (0.214 mmol), N-[4-(3
-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide dihydrochloride 112 mg (0.385 mmol), glutaric acid 70 mg (0.53 mmol) and water
0.07 ml (3.9 mmol) was mixed and stirred at 60°C for 43 hours. Add 20ml of 0.4M NaCl to the reaction solution, adjust the pH to 6.1 with 10% aqueous ammonia, and equilibrate with 0.4M NaCl.
Pour 20 ml of CM-Sephadex C-25 into a column (inner diameter 12 mm), then add 80 ml each of 0.4M and
Gradient elution with 1.0 M NaCl was performed (2 ml fractions). Fractions 41-50 were combined, concentrated to dryness, and extracted three times with 10 ml of methanol. A tower (inner diameter
20 mm) and developed with methanol (1 ml fractions).
Fractions 30-42 were combined and concentrated to dryness.
aminopropyl) aminobutyl]-2-[(S)-7
-guanidino-3-hydroxyheptanamide]
38.4 mg of white powder of -2-hydroxyethanamide (GHA-GS) trihydrochloride was obtained. Yield 35%. GHA-GS trihydrochloride is a hygroscopic powder, and a clear melting point could not be determined, showing [α] 22 D −1° ± 2° (C2, water). The elemental analysis values matched the theoretical values of C17H37N7O4.3HCl ( C39.81%, H7.86%, N19.12 % , Cl20.73%). Proton NMR measured in heavy water shows δ1.8−2.3 (CH 2 ×5), 2.57 (6″−CH 2 ), 2.95 (2
−
CH 2 ), 3.5−3.8 (NCH 2 ×5), 4.55 (3−CH),
A characteristic signal was shown at 5.98 (2'-CH). Note that N-[4-(3-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide used in this reference example is produced as follows. Synthesis of N-[4-(3-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide (a) Mono-N-benzyloxycarbonyl-1.
Synthesis of 4-butanediamine 1.76 g (20 mmol) of 1,4-butanediamine was dissolved in 30 ml of 50% methanol water, and benzyl S-4,6-dimethylpyrimid-2-ylthiocarbonate (Kokusan Kagaku Co., Ltd.) was dissolved in 30 ml of 50% methanol water. Add 5.48 g (20 mmol) of M. Co., Ltd.) and stir for 3 hours. After the reaction, the precipitate was removed (2.08 g, 29% of di-N-benzyloxycarbonyl compound was obtained), and the liquid was concentrated to dryness. Dissolve the residue in 250ml of chloroform,
Washed 5 times with 100 ml of water, dehydrated the chloroform layer with anhydrous sodium sulfate, concentrated to dryness, and mono-
1.0 g of a colorless candy-like substance of N-benzyloxycarbonyl-1,4-butanediamine was obtained. Yield 23%. (b) Synthesis of 0-tosyl-3-tert-butoxycarbonylamino-1-propanol 1.5 g (20 mmol) of 3-amino-1-propanol was dissolved in 30 ml of methanol, and tert-butyl S-4,6-dimethylpyrylene was dissolved in 30 ml of methanol. 4.8 g (20 mmol) of mid-2-ylthiocarbonate (manufactured by Kokusan Kagaku Co., Ltd.) was added and stirred for 6 hours. Concentrate the reaction solution to dryness, dissolve in 200 ml of chloroform, and add 200 ml of
Washed with water. The chloroform layer was concentrated and subjected to column chromatography using 300 g of silica gel (Wako Gel C-200) and developed with a mixture of toluene and ethyl acetate (1:1 volume) (15 ml fractions).
Fractions 82-151 were combined and concentrated to dryness to obtain 2.95 g of 3-tert-butoxycarbonylamino-1-propanol as a colorless oil. Yield 84%. 2.95 g (16.9 mmol) of 3-tert-butoxycarbonylamino-1-propanol was added to pyridine.
The mixture was diluted to 50 ml, and a pyridine solution containing 3.36 g (17.7 mmol) of paratoluenesulfonyl chloride was added dropwise over 40 minutes under ice-cooling in argon. After further standing at 7°C overnight, a small amount of water was added and the mixture was concentrated to dryness. Dissolve the residue in 200ml of chloroform,
After sequentially washing with 5% potassium hydrogen sulfate aqueous solution, saturated sodium hydrogen carbonate aqueous solution, and water,
It was dehydrated with anhydrous sodium sulfate and concentrated to dryness.
Add this to 120g of silica gel (Wakogel C-200)
Column chromatography using toluene
Developed with a mixture of ethyl acetate (8:1 volume) (15 ml
fractions), fractions 35-68 were combined, concentrated to dryness, and 0-
Tosyl-3-tert-butoxycarbonylamino-
3.06 g of a colorless oil of 1-propanol was obtained. Yield 55%. (c) N-tert-butoxycarbonyl-N-(tert-butoxycarbonylaminopropyl)-1,4-
Synthesis of butanediamine 800 mg of 0-tosyl-3-tert-butoxycarbonylamino-1-propanol obtained in section (b)
(2.43 mmol) in 15 ml of dimethylformamide
510 mg of lithium bromide (LiBrH 2 O)
(4.8 mmol) was added and stirred at room temperature for 24 hours.
The monomer obtained in section (a) is added to the reaction solution of this bromine compound.
540 mg (2.43 mmol) of N-benzyloxycarbonyl-1,4-butanediamine and 0.34 ml of triethylamine were added, and the mixture was stirred at room temperature for 48 hours. Add tert-butyl S-4,6-dimethylpyrimid-2-ylthiocarbonate to this reaction solution.
mg (2.9 mmol) was added and stirred at room temperature for 13 hours. The reaction solution was concentrated to dryness, the residue was dissolved in 100 ml of chloroform, and washed with 50 ml of water.
It was dehydrated with anhydrous sodium sulfate and concentrated to dryness. This was developed by column chromatography using 200 g of silica gel (Wako Gel C-200) with a mixture of toluene and ethyl acetate (4:1 volume) (12 ml fractions), and fractions 134 to 165 were combined and concentrated to dryness. , N-
608 mg of a colorless candy-like substance of benzyloxycarbonyl-N'-tert-butoxycarbonyl-N'-(tert-butoxycarbonylaminopropyl)-1,4-butanediamine was obtained. Yield 52%. 144 mg (0.3 mmol) of this candy-like substance was dissolved in 5 ml of methanol, 100 mg of 5% palladium-barium carbonate was added, and the mixture was stirred at room temperature in a hydrogen stream for 5 hours. The catalyst was removed and the liquid was concentrated to dryness to give N-tert-butoxycarbonyl-N-(tert-butoxycarbonylaminopropyl)-1.4
-103 mg of butanediamine were obtained. Yield 100%. (d) Synthesis of N-[4-(3-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide N-tert-butoxycarbonyl-N obtained in section (c)
-(tert-butoxycarbonylaminopropyl)-
1,4-butanediamine 100 mg (0.29 mmol)
and 148 mg (1 mmol) of 2,2-diethoxyacetic acid
Dissolve in 2 ml of ethyl acetate and add 135 mg (1 mmol) of 1-hydroxybenztriazole.
and dicyclohexylcarbodiimide 206mg
(1 mmol) was added and stirred at room temperature for 15 hours.
The precipitate was removed and washed with cold ethyl acetate, and the liquid and washing liquid were combined and washed successively with 1M aqueous ammonia and water. The ethyl acetate layer was dehydrated over anhydrous sodium sulfate and concentrated to dryness. This was subjected to column chromatography using 20 g of silica gel (Wako Gel C-200) using toluene-ethyl acetate (1:2 volume).
(3 ml fractions), and fractions 14-21 were combined and concentrated to dryness to give N-[4-(3-tert-butoxycarbonylaminopropyl)-4-tert-butoxycarbonylaminobutyl]. 109 mg of a colorless candy-like substance of -2,2-diethoxyethanamide was obtained. Yield 79%. Dissolve 44 mg (0.13 mmol) of this candy-like substance in 1 ml of dioxane, add 2.5 ml of 0.1N hydrochloric acid,
The mixture was stirred in a 100°C oil bath for 4 hours. reaction solution
It was neutralized with 0.2N NaOH (PH6) and concentrated to dryness.
Extract the residue with 1.5 ml of methanol and apply it to a Sephadex LH-20 100 ml column (inner diameter 16.5 mm).
and developed with methanol (2 ml fractions). Fractions 22-25 positive for ninhydrin reaction were combined and concentrated to dryness to yield 13 mg of a colorless candy-like substance of N-[4-(3-aminopropyl)aminobutyl]-2,2-dihydroxyethanamide dihydrochloride. I got it. Yield 46%.
Claims (1)
ロキシヘプタンアミドおよびその酸付加塩。 2 次式() で表わされるL−リジンの2個のアミノ基をアミ
ノ保護基で保護し、続いて常法により酸塩化物と
し、ジアゾメタンで処理したのち、メタノール中
安息香酸銀を触媒として転移反応を行ない、アミ
ノ保護基およびカルボキシル保護基を除去して、
次式() で表わされる(S)−3・7−ジアミノヘプタン
酸とし、末端アミノ基のみをアミノ保護基で保護
し、β−アミノ基を亜硝酸塩で脱アミノ化し、続
いてカルボキシル基をエステル化し、アンモニア
で処理してアミド化し、アミノ保護基を除去し
て、次式() で表わされる(S)−7−アミノ−3−ヒドロキ
シヘプタン酸アミドとし、続いて7位のアミノ基
を常法によりグアニジン基に変換することを特徴
とする次式() で表わされる(S)−7−グアニジノ−3−ヒド
ロキシヘプタンアミドの製造法。[Claims] Linear formula () (S)-7-guanidino-3-hydroxyheptanamide represented by and its acid addition salt. Quadratic formula () The two amino groups of L-lysine represented by removing the protecting groups and carboxyl protecting groups;
The following formula () (S)-3,7-diaminoheptanoic acid represented by (S)-3,7-diaminoheptanoic acid was prepared, only the terminal amino group was protected with an amino protecting group, the β-amino group was deaminated with nitrite, the carboxyl group was subsequently esterified, and the After treatment to amidate and remove the amino protecting group, the following formula () (S)-7-amino-3-hydroxyheptanoic acid amide represented by the following formula (), which is characterized by converting the amino group at position 7 to a guanidine group by a conventional method. A method for producing (S)-7-guanidino-3-hydroxyheptanamide represented by
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56073511A JPS57188562A (en) | 1981-05-18 | 1981-05-18 | (s)-7-guanidino-3-hydroxyheptanamide and its synthesis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP56073511A JPS57188562A (en) | 1981-05-18 | 1981-05-18 | (s)-7-guanidino-3-hydroxyheptanamide and its synthesis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS57188562A JPS57188562A (en) | 1982-11-19 |
| JPS634821B2 true JPS634821B2 (en) | 1988-02-01 |
Family
ID=13520340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56073511A Granted JPS57188562A (en) | 1981-05-18 | 1981-05-18 | (s)-7-guanidino-3-hydroxyheptanamide and its synthesis |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS57188562A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0337013U (en) * | 1989-08-23 | 1991-04-10 |
-
1981
- 1981-05-18 JP JP56073511A patent/JPS57188562A/en active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0337013U (en) * | 1989-08-23 | 1991-04-10 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS57188562A (en) | 1982-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5965592A (en) | Acyl compounds | |
| US5084466A (en) | Novel carboxamide pyridine compounds which have useful pharmaceutical utility | |
| US4518532A (en) | N-[4-(3-aminopropyl)-aminobutyl]-2-(ω-guanidino-fatty-acid-amido)-2-substituted-ethanamide and salt thereof | |
| JPH08504191A (en) | Nitrate ester having pharmacological activity and method for producing the same | |
| WO1999001420A1 (en) | Process for the preparation of 2-aminomalonic acid derivatives and intermediates used in the process | |
| CZ44293A3 (en) | Novel process for preparing formoterol and related compounds | |
| US4430346A (en) | Novel carcinostatic substance and process for synthesis thereof | |
| ES2664050T3 (en) | Processes for the synthesis of 2-amino-4,6-dimethoxybenzamide and other benzamide compounds | |
| CS257292B2 (en) | Production method of amikacine | |
| KR900001076B1 (en) | Method for preparing N- [4- (3-aminopropyl) aminobutyl] -2,2-dihydroxyethaneamide | |
| GB2184121A (en) | Phenethyl sulphides and their use as leukotriene antagonists | |
| JPS6312063B2 (en) | ||
| JP2670032B2 (en) | Method for producing 1-N-ethylsisomycin | |
| JPH0259140B2 (en) | ||
| KR20150066777A (en) | Indoline derivatives and method of preparing the same | |
| JPH0228143A (en) | Amide compound, production thereof and inhibitor of glutamic acid receptor | |
| JPH05500214A (en) | Novel synthesis method for tertiary alkyl esters | |
| JP2531501B2 (en) | N-chloroacetyl glutamic acid γ-lower alkyl ester ammonium salt | |
| JPS61106569A (en) | Intermediates for branched chain amides of l-aspartyl-d-amino acid dipeptide | |
| JPH0699473B2 (en) | Glycyl-Glutamine production method | |
| US6677483B2 (en) | Process for the production of monoamides of DTPA | |
| JP3657118B2 (en) | Method for producing theanine | |
| JP2003533506A5 (en) | N-substituted peptidyl nitriles as cysteine cathepsin inhibitors | |
| JP3145533B2 (en) | New methotrexate derivatives | |
| JPS6210500B2 (en) |